The investigational drug DEDN6526A, which is a new member of a class of drugs called antibody-drug conjugates, was safe, tolerable, and showed hints of activity against different forms of melanoma—cutaneous, mucosal, and ocular—according to results of a first-in-human phase I clinical trial presented here at the AACR Annual Meeting 2014, April 5-9.
Health Professional Events
Venues & Events World’s leading Melanoma experts to meet in Brisbane
Brisbane has won the right to host up to 1,500 of the world’s leading Melanoma and skin cancer experts. Queensland has the highest incidence of skin cancer in the world. Every year skin cancers account for 80% of all newly diagnosed cancers, with medical practitioners providing more than one million patient consultations resulting in a significant burden on the state’s health care system.
Fundraiser for Melanoma Research
Ten thousand dollars was raised for melanoma research at the Jennnifer’s Journey Melanoma Charity Ball held in Geelong on Saturday 12th October 2013. The sold out evening was put together…
Read More 2013 MMP Scientific Exchange Meeting
The 2013 Melbourne Melanoma Project (MMP) Scientific Exchange Meeting, held on Monday 14th October, was well attended by a mix of patients, survivors, carers, clinicians, health professionals and scientists. MMP…
Read More